斯科特·戴维斯出售323股Illumina公司（纳斯达克：ILMN）股票 - MarketBeat
Scott Davies Sells 323 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat
生命科学资讯
生物技术与制药领域的最新动态
Illumina将在雅虎财经新加坡频道直播即将举行的投资者大会。
Illumina To Webcast Upcoming Investor Conference - Yahoo Finance Singapore
如何观看Illumina在J.P.摩根医疗健康大会的网络直播 - Stock Titan
How to watch Illumina's J.P. Morgan healthcare conference webcast - Stock Titan
探秘Illumina空间分析技术突破背后的三位科学家
Meet three scientists behind Illumina’s spatial assay breakthrough - Illumina
无细胞DNA检测市场即将迎来繁荣 |• Illumina • Guardant Health - openPR.com
Cell Free DNA Testing Market Is Going to Boom |• Illumina • Guardant Health - openPR.com
系统双基因组分裂绿色荧光蛋白测定揭示线粒体基质蛋白质组及蛋白靶向路径
A systematic bi-genomic split-GFP assay illuminates the mitochondrial matrix proteome and protein targeting routes
摩根大通为Illumina设定新目标价130美元 - MarketBeat
Illumina (NASDAQ:ILMN) Given New $130.00 Price Target at JPMorgan Chase & Co. - MarketBeat
扭曲、纠缠与转录：表观遗传学在阿尔茨海默病中起作用吗？- Illumina
Twists, tangles, and transcription: Does epigenetics play a role in Alzheimer's? - Illumina
Marex集团对Illumina公司进行124万美元新投资，股票代码$ILMN - MarketBeat报道
Marex Group plc Makes New $1.24 Million Investment in Illumina, Inc. $ILMN - MarketBeat
空间转录组学市场即将迎来繁荣 |• 10X Genomics • Illumina - openPR.com
Spatial Transcriptomics Market Is Going to Boom |• 10X Genomics • Illumina - openPR.com
Illumina与MyOme的AI基因组学合作可能改变投资Illumina（ILMN）的理由 - simplywall.st
Illumina’s AI Genomics Partnership With MyOme Might Change The Case For Investing In Illumina (ILMN) - simplywall.st
Nikko Asset Management Americas Inc. 增持 Illumina, Inc. $ILMN 股份 - MarketBeat
Nikko Asset Management Americas Inc. Increases Stake in Illumina, Inc. $ILMN - MarketBeat
4D Advisors LLC购入30,000股Illumina公司股票 $ILMN - MarketBeat
4D Advisors LLC Purchases Shares of 30,000 Illumina, Inc. $ILMN - MarketBeat
Illumina战略举措预示增长轨迹 - Ad-hoc-news.de
Illumina’s Strategic Moves Signal Growth Trajectory - Ad-hoc-news.de
您实验室进行可扩展蛋白质组学的新伙伴：Illumina蛋白质制备套件
Your lab’s new best friend for scalable proteomics: Illumina Protein Prep - Illumina
Illumina与MyOme达成合作协议，包含战略投资以支持MyOme临床试验，该项目有望每年为美国医疗系统节省2000亿美元——marketscreener.com报道
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - marketscreener.com
Illumina与MyOme达成合作协议，包含战略投资以支持MyOme临床试验，有望每年为美国医疗系统节省2000亿美元 | Newswise - Newswise
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually | Newswise - Newswise
Illumina（纳斯达克代码：ILMN）投资MyOme，计划2026年启动AI驱动的全基因组测序试验 - 股票泰坦
Illumina (NASDAQ: ILMN) invests in MyOme to launch AI-driven WGS trial in 2026 - Stock Titan
Illumina与MyOme达成合作及战略投资协议，支持其临床试验，有望为美国医疗系统年省2000亿美元
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - PR Newswire
Stifel重申Illumina股票买入评级，指出多重增长动力 - Investing.com UK
Stifel reiterates Buy rating on Illumina stock, cites multiple growth levers - Investing.com UK